Changhua Yu

Changhua Yu

Auto-generated profile, based on publicly available information

Changhua Yu

California Institute of Technology

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2019 in Nature
Verified
Journal Article
Closed access
PDF file
XLXiaozhou Luo
Xiaozhou Luo
MRMichael A. Reiter
Michael A. Reiter
LDLeo D’eSpaux
Leo D’eSpaux
JWJeff Wong
Jeff Wong
CDCharles M. Denby
Charles M. Denby
JKJay D. Keasling
Jay D. Keasling

1 December 2021 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
JCJohn-Marc Chandonia
John-Marc Chandonia
LGLindsey Guan
Lindsey Guan
SLShiangyi Lin
Shiangyi Lin
CYChanghua Yu
Changhua Yu
NFNaomi K Fox
Naomi K Fox
SBSteven E Brenner
Steven E Brenner
The Structural Classification of Proteins—extended (SCOPe, https://scop.berkeley.edu) knowledgebase aims to provide an accurate, detailed, and comprehensive description of the structural and evolutionary relationships amongst the majority of proteins of known structure, along with resources for analyzing the protein structures and their sequences. Structures from the PDB are divided into domains and classified using a combination of manual curation and highly precise automated methods. In the current release of SCOPe, 2.08, we have developed search and display tools for analysis of genetic variants we mapped to structures classified in SCOPe. In order to improve the utility of SCOPe to automated methods such as deep learning classifiers that rely on multiple alignment of sequences of homologous proteins, we have introduced new machine-parseable annotations that indicate aberrant structures as well as domains that are distinguished by a smaller repeat unit. We also classified structures from 74 of the largest Pfam families not previously classified in SCOPe, and we improved our algorithm to remove N- and C-terminal cloning, expression and purification sequences from SCOPe domains. SCOPe 2.08-stable classifies 106 976 PDB entries (about 60% of PDB entries).

17 August 2019 in Human Mutation
Verified
Journal Article
Closed access
PDF file
ZHZhiqiang Hu
Zhiqiang Hu
CYChanghua Yu
Changhua Yu
MFMabel Furutsuki
Mabel Furutsuki
GAGaia Andreoletti
Gaia Andreoletti
MLMelissa Ly
Melissa Ly
SBSteven E. Brenner
Steven E. Brenner

13 July 2019 in Human Mutation
Verified
Journal Article
Closed access
PDF file
LKLaura Kasak
Laura Kasak
CBConstantina Bakolitsa
Constantina Bakolitsa
ZHZhiqiang Hu
Zhiqiang Hu
CYChanghua Yu
Changhua Yu
JRJasper Rine
Jasper Rine
IFIddo Friedberg
Iddo Friedberg

21 November 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
AVArchit Verma
Archit Verma
CYChanghua Yu
Changhua Yu
SBStefanie Bachl
Stefanie Bachl
ILIvan Lopez
Ivan Lopez
MSMorgan Sarah Schwartz
Morgan Sarah Schwartz
BEBarbara Engelhardt
Barbara Engelhardt
T cell therapies, such as chimeric antigen receptor (CAR) T cells and T cell receptor (TCR) T cells, are a growing class of anti-cancer treatments. However, expansion to novel indications and beyond last-line treatment requires engineering cells’ dynamic population behaviors. Here we develop the tools for cellular behavior analysis of T cells from live-cell imaging, a common and inexpensive experimental setup used to evaluate engineered T cells. We first develop a state-of-the-art segmentation and tracking pipeline, Caliban , based on human-in-the-loop deep learning. We then build the Occident pipeline to collect a catalog of phenotypes that characterize cell populations, morphology, movement, and interactions in co-cultures of modified T cells and antigen-presenting tumor cells. We use Caliban and Occident to interrogate how interactions between T cells and cancer cells differ when beneficial knock-outs of RASA2 and CUL5 are introduced into TCR T cells. We apply spatiotemporal models to quantify T cell recruitment and proliferation after interactions with cancer cells. We discover that, compared to a safe harbor knockout control, RASA2 knockout T cells have longer interaction times with cancer cells leading to greater T cell activation and killing efficacy, while CUL5 knockout T cells have increased proliferation rates leading to greater numbers of T cells for hunting. Together, segmentation and tracking from Caliban and phenotype quantification from Occident enable cellular behavior analysis to better engineer T cell therapies for improved cancer treatment.